Vera is taking a break from the alternative medical approach project. I thought I'd submit another. I recently ran into a fellow I have known for several...
B Howes
bhowes@...
Dec 1, 1997 8:09 pm
170
Besides the main press release on Rituxan, I wanted to get my arms around many the other press releases. (Most of you know how I like to consolidate). Anyway,...
Janice and Ben
jbhaines@...
Dec 2, 1997 5:30 am
171
I was referred to your web site from the NHL newsgroup. Can you provide the URL? Thank you. -- Debra M. Heit President HeiTech Technologies ...
Debra M. Heit
dheit@...
Dec 2, 1997 7:40 pm
172
Hello all, My terrific mother gave me a really interesting article from Woman's Day, called "Medical Wonders," written by Susan Chollar, November 18,1997, ...
Janice and Ben
jbhaines@...
Dec 3, 1997 1:22 am
173
Just a clarification -- will rate this therapy a B -- for interesting, even promising, but no data re lymphoma (unfortunately). Vera...
VBradova@...
Dec 3, 1997 4:53 am
174
Folks, please edit the post when you reply so you don't send the WHOLE article back to the board (because it makes it very boring to have 80 people reread it)...
Janice and Ben
jbhaines@...
Dec 3, 1997 4:26 am
175
Here are 4 Articles and 1 e-mail Reply Article 1: G3139 Article 2,3,4: Rituxan e-mail reply: Rituxan -vs- Bexxar -Ben (KIA) ... Article 1 compiled by nhl-low...
BEN HAINES
BHAINES2@...
Dec 4, 1997 4:21 pm
176
A Pilot Study on the Use of the ProMACE-CytaBOM Regimen as a First-Line Treatment of Advanced Follicular Non-Hodgkin's Lymphoma Luca Baldini, M.D.1 Andrea...
BEN HAINES
BHAINES2@...
Dec 4, 1997 4:40 pm
177
Abstract from: http://journals.wiley.com/wil-bin/search A Pilot Study on the Use of the ProMACE-CytaBOM Regimen as a First-Line Treatment of Advanced...
BEN HAINES
BHAINES2@...
Dec 4, 1997 4:27 pm
178
This is my fourth attempt to send this post to the board over 2 days now, let me know if anyone else has trouble sending to nhl-low@... It appears to...
BEN HAINES
BHAINES2@...
Dec 4, 1997 9:24 pm
179
Hi Everybody! Sometime back I told you about my wife, Marcia, 72, dx 9/97 type B small cell NHL, stage III/IV, just starting CVP. She's had her problems with ...
Murray Prester
murbabes@...
Dec 5, 1997 4:40 am
180
Coulter's stock jumped today as a result of a presentation they made today to the American Society of Hematology annual meeting in San Diego. I don't have any...
BEN HAINES
BHAINES2@...
Dec 5, 1997 11:16 pm
181
... John, to my knowledge, once drugs are approved, then can then be used "off- label" -- it's up to the physician to decide this, and is within the law. A ...
VBradova
VBradova@...
Dec 6, 1997 6:42 am
182
Folks, I wonder if anyone here can help me understand this abstract. ... What are WF histotypes? ... survival >rate was 60%. Now if 55% of the patients...
VBradova
VBradova@...
Dec 6, 1997 6:43 am
183
... Jim, thanks for the confirmation. The dr I saw at SK last spring felt it was not a good idea to do Rituxan alone, as a first line, because it does not ...
VBradova
VBradova@...
Dec 7, 1997 1:44 am
184
Well, I am finally off Scott's other list that is A LOT different than nhl-low, his is mostly support and it serves many useful purposes and helped me out even...
Janice and Ben
jbhaines@...
Dec 7, 1997 3:07 am
185
... I didn't realize there are costs - since we all benefit, I believe we should share those costs. I would be happy to do so. Thanks again. Gloria Blumenthal...
Gloria Blumenthal
blumenth@...
Dec 7, 1997 5:13 pm
186
To all, We are seeing double postings again and it has to be related to one of the people on here. Tough to find, bear with me as I try to find out who it is, ...
Janice and Ben
jbhaines@...
Dec 7, 1997 8:37 pm
187
Phase II Trial of Docetaxel in Non-Hodgkin's Lymphomas: A Study of the Cancer and Leukemia Group B By Daniel R. Budman, Gina R. Petroni, Jeffery L. Johnson, M....
Janice and Ben
jbhaines@...
Dec 7, 1997 9:14 pm
188
Comparison in Low-Tumor-Burden Follicular Lymphomas Between an Initial No-Treatment Policy, Prednimustine, or Interferon Alfa: A Randomized Study From the...
Janice and Ben
jbhaines@...
Dec 7, 1997 9:23 pm
189
Role of a Second Transplant in the Management of Poor-Prognosis Lymphomas: A Report From the European Blood and Bone Marrow Registry By E. Vandenberghe, R....
Janice and Ben
jbhaines@...
Dec 7, 1997 9:19 pm
190
December 7, 1997 Backlash: In Medicine, Government Rises Again By PETER PASSELL <Picture: H>illary was right about health care. Well, not quite: Hardly anybody...
DebLarson
DebLarson@...
Dec 8, 1997 3:32 am
191
Genzyme Transgenics' Cancer Vaccine Produces Tumor-Specific Immune Responses in Lymphoma Patients DATE: December 8, 1997 Genzyme Transgenics Corp....
BEN HAINES
BHAINES2@...
Dec 8, 1997 7:58 pm
192
PISCATAWAY, NJ--(BW HealthWire)--December 2, 1997--Enzon, Inc. (NASDAQ:ENZN) announced today that its marketing partner for ONCASPAR(R), Rhone-Poulenc Rorer...
BEN HAINES
BHAINES2@...
Dec 8, 1997 8:01 pm
193
Chemotherapy Comparisons I read with considerable vested interest "Making Drug To 'Chase Down' Cancer Cells" (New America, Nov. 25), which deals with Coulter ...
BEN HAINES
BHAINES2@...
Dec 8, 1997 8:10 pm
194
I'm writing to you from the Lymphoma Research Foundation of America. I have noticed recently a number of questions regarding Rituxan - and I was just ...
LRFA
LRFA@...
Dec 8, 1997 9:36 pm
195
Tuesday December 9, 8:01 am Eastern Time Company Press Release REPEAT/Coulter Pharmaceutical Reports Phase II Results of Bexxar Multicenter Trial Demonstrates...
BEN HAINES
BHAINES2@...
Dec 9, 1997 4:03 pm
196
"PROMISING PROTOCOLS for Low Grade Non-Hodgkin's Lymphoma" compiled by the nhl-low@... mailing list ...
BEN HAINES
BHAINES2@...
Dec 9, 1997 8:53 pm
197
**Welcome new subscribers, especially a guy with intials R.T.** He was one of the reasons I started this list, a long story. Now serving 83. -Ben (KIA) ...
Janice and Ben
jbhaines@...
Dec 10, 1997 3:53 am
198
Tuesday December 9, 6:42 pm Eastern Time Company Press Release IDEC Pharmaceuticals Reports Interim Results of Phase I/II Trial of IDEC-Y2B8 in the Treatment...
